The Drug-Resistance Mechanisms of Five Platinum-Based Antitumor Agents
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The Drug-Resistance Mechanisms of Five Platinum-Based Antitumor Agents
Authors
Keywords
-
Journal
Frontiers in Pharmacology
Volume 11, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2020-03-20
DOI
10.3389/fphar.2020.00343
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- HIF-1-Dependent Reprogramming of Glucose Metabolic Pathway of Cancer Cells and Its Therapeutic Significance
- (2019) Ayako Nagao et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Profiling of apoptosis- and autophagy-associated molecules in human lung cancer A549 cells in response to cisplatin treatment using stable isotope labeling with amino acids in cell culture
- (2019) Zongqiang Wang et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Tetrathiomolybdate induces dimerization of the metal-binding domain of ATPase and inhibits platination of the protein
- (2019) Tiantian Fang et al. Nature Communications
- Regulation of OCT2 transcriptional repression by histone acetylation in renal cell carcinoma
- (2019) Qianying Zhu et al. Epigenetics
- Cisplatin resistance involves a metabolic reprogramming through ROS and PGC-1α in NSCLC which can be overcome by OXPHOS inhibition
- (2019) Alberto Cruz-Bermúdez et al. FREE RADICAL BIOLOGY AND MEDICINE
- Inositol-triphosphate 3-kinase B confers cisplatin resistance by regulating NOX4-dependent redox balance
- (2019) Chaoyun Pan et al. JOURNAL OF CLINICAL INVESTIGATION
- Loss of Scribble confers cisplatin resistance during NSCLC chemotherapy via Nox2/ROS and Nrf2/PD-L1 signaling
- (2019) Na Wang et al. EBioMedicine
- Reversal of cisplatin resistance by microRNA-139-5p-independent RNF2 downregulation and MAPK inhibition in ovarian cancer
- (2018) Ying Chen et al. AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY
- Gambogic Acid Inhibits Melanoma through Regulation of miR-199a-3p/ZEB1 Signalling
- (2018) Lili Liang et al. BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY
- MircroRNA-139 sensitizes ovarian cancer cell to cisplatin-based chemotherapy through regulation of ATP7A/B
- (2018) Fang Xiao et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- DUOXA1-mediated ROS production promotes cisplatin resistance by activating ATR-Chk1 pathway in ovarian cancer
- (2018) Yunxiao Meng et al. CANCER LETTERS
- Phase II study of adjuvant chemotherapy with paclitaxel and nedaplatin for uterine cervical cancer with lymph node metastasis
- (2018) Munetaka Takekuma et al. CANCER SCIENCE
- Targeting the microenvironment in solid tumors
- (2018) Carmen Belli et al. CANCER TREATMENT REVIEWS
- BRCA Mutation and Its Association With Colorectal Cancer
- (2018) Aixa E. Soyano et al. Clinical Colorectal Cancer
- Knockdown of long non-coding RNA HOTAIR inhibits cisplatin resistance of gastric cancer cells through inhibiting the PI3K/Akt and Wnt/β-catenin signaling pathways by up-regulating miR-34a
- (2018) Chuanyao Cheng et al. INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
- ABT737 reverses cisplatin resistance by targeting glucose metabolism of human ovarian cancer cells
- (2018) Yunjie Xu et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- MicroRNA-125a-5p enhances the sensitivity of esophageal squamous cell carcinoma cells to cisplatin by suppressing the activation of the STAT3 signaling pathway
- (2018) Yan Zhao et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Knockdown of KLF5 suppresses hypoxia-induced resistance to cisplatin in NSCLC cells by regulating HIF-1α-dependent glycolysis through inactivation of the PI3K/Akt/mTOR pathway
- (2018) Tianxiao Gong et al. Journal of Translational Medicine
- Relevance of copper transporter 1 and organic cation transporters 1–3 for oxaliplatin uptake and drug resistance in colorectal cancer cells
- (2018) I. Buß et al. Metallomics
- Autocrine activation of JAK2 by IL-11 promotes platinum drug resistance
- (2018) Wei Zhou et al. ONCOGENE
- miR-181 regulates cisplatin-resistant non-small cell lung cancer via downregulation of autophagy through the PTEN/PI3K/AKT pathway
- (2018) Jiangang Liu et al. ONCOLOGY REPORTS
- A HIF-independent, CD133-mediated mechanism of cisplatin resistance in glioblastoma cells
- (2018) Eroje M. Ahmed et al. CELLULAR ONCOLOGY
- Downregulation of HIF-2α Reverse the Chemotherapy Resistance of Lung Adenocarcinoma A549 Cells to Cisplatin
- (2018) Zhao-jia Gao et al. MEDICAL SCIENCE MONITOR
- Cisplatin and Pemetrexed Activate AXL and AXL Inhibitor BGB324 Enhances Mesothelioma Cell Death from Chemotherapy
- (2018) Derek B. Oien et al. Frontiers in Pharmacology
- LncRNA HOXA11-AS drives cisplatin resistance of human LUAD cells via modulating miR-454-3p/Stat3
- (2018) Xia Zhao et al. CANCER SCIENCE
- miR-137 mediates the functional link between c-Myc and EZH2 that regulates cisplatin resistance in ovarian cancer
- (2018) Jing Sun et al. ONCOGENE
- Comparison of efficacy and toxicity between nedaplatin and cisplatin in treating malignant pleural effusion
- (2018) Li-Zhe Zhong et al. OncoTargets and Therapy
- Induction of p53 Phosphorylation at Serine 20 by Resveratrol Is Required to Activate p53 Target Genes, Restoring Apoptosis in MCF-7 Cells Resistant to Cisplatin
- (2018) Jorge Hernandez-Valencia et al. Nutrients
- Knockdown of galectin-1 facilitated cisplatin sensitivity by inhibiting autophagy in neuroblastoma cells
- (2018) Jie Gao et al. CHEMICO-BIOLOGICAL INTERACTIONS
- Omeprazole protects against cisplatin-induced nephrotoxicity by alleviating oxidative stress, inflammation, and transporter-mediated cisplatin accumulation in rats and HK-2 cells
- (2018) Huan Gao et al. CHEMICO-BIOLOGICAL INTERACTIONS
- Activated Integrated Stress Response Induced by Salubrinal Promotes Cisplatin Resistance in Human Gastric Cancer Cells via Enhanced xCT Expression and Glutathione Biosynthesis
- (2018) Sheng-Fan Wang et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- miR-874 regulates multiple-drug resistance in gastric cancer by targeting ATG16L1
- (2018) Haijin Huang et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- LncRNA MALAT1 potentiates autophagy‑associated cisplatin resistance by regulating the microRNA‑30b/autophagy‑related gene 5 axis in gastric cancer
- (2018) Zhiwen Xi et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- LncRNA BLACAT1 is involved in chemoresistance of non‑small cell lung cancer cells by regulating autophagy
- (2018) Feng‑Xiang Huang et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- miR‑34a regulates the chemosensitivity of retinoblastoma cells via modulation of MAGE‑A/p53 signaling
- (2018) Ge Yang et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Therapy resistance mediated by cancer stem cells
- (2018) Teresa Bernadette Steinbichler et al. SEMINARS IN CANCER BIOLOGY
- A Whole-genome CRISPR Screen Identifies a Role of MSH2 in Cisplatin-mediated Cell Death in Muscle-invasive Bladder Cancer
- (2018) Andrew Goodspeed et al. EUROPEAN UROLOGY
- miR-148a increases the sensitivity to cisplatin by targeting Rab14 in renal cancer cells
- (2017) Eun-Ae Kim et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- PGRMC1-dependent autophagy by hyperoside induces apoptosis and sensitizes ovarian cancer cells to cisplatin treatment
- (2017) Xiaofei Zhu et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Resveratrol-induced autophagy and apoptosis in cisplatin-resistant human oral cancer CAR cells: A key role of AMPK and Akt/mTOR signaling
- (2017) Chao-Hsiang Chang et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Interactions of cisplatin and the copper transporter CTR1 in human colon cancer cells
- (2017) Mia C. Akerfeldt et al. JOURNAL OF BIOLOGICAL INORGANIC CHEMISTRY
- Exosomal transfer of tumor-associated macrophage-derived miR-21 confers cisplatin resistance in gastric cancer cells
- (2017) Peiming Zheng et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Competitive reactions among glutathione, cisplatin and copper-phenanthroline complexes
- (2017) Enzo Cadoni et al. JOURNAL OF INORGANIC BIOCHEMISTRY
- Glutathione reductase mediates drug resistance in glioblastoma cells by regulating redox homeostasis
- (2017) Zhongling Zhu et al. JOURNAL OF NEUROCHEMISTRY
- Histone Methyltransferase G9a Drives Chemotherapy Resistance by Regulating the Glutamate–Cysteine Ligase Catalytic Subunit in Head and Neck Squamous Cell Carcinoma
- (2017) Chia-Wen Liu et al. MOLECULAR CANCER THERAPEUTICS
- MiR-5100 increases the cisplatin resistance of the lung cancer stem cells by inhibiting the Rab6
- (2017) Lawei Yang et al. MOLECULAR CARCINOGENESIS
- ABCF2 , an Nrf2 target gene, contributes to cisplatin resistance in ovarian cancer cells
- (2017) Lingjie Bao et al. MOLECULAR CARCINOGENESIS
- Mxd1 mediates hypoxia-induced cisplatin resistance in osteosarcoma cells by repression of the PTEN tumor suppressor gene
- (2017) Datong Zheng et al. MOLECULAR CARCINOGENESIS
- A subset of platinum-containing chemotherapeutic agents kills cells by inducing ribosome biogenesis stress
- (2017) Peter M Bruno et al. NATURE MEDICINE
- RAD6 promotes DNA repair and stem cell signaling in ovarian cancer and is a promising therapeutic target to prevent and treat acquired chemoresistance
- (2017) R R Somasagara et al. ONCOGENE
- Lysine-specific demethylase KDM3A regulates ovarian cancer stemness and chemoresistance
- (2017) S Ramadoss et al. ONCOGENE
- Classification Systems of Secondary Active Transporters
- (2017) Emelie Perland et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- miR-34a mediates oxaliplatin resistance of colorectal cancer cells by inhibiting macroautophagy via transforming growth factor-β/Smad4 pathway
- (2017) Chen Sun et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Cytoplasmic fragment of CD147 generated by regulated intramembrane proteolysis contributes to HCC by promoting autophagy
- (2017) Bo Wu et al. Cell Death & Disease
- USP13 regulates the RAP80-BRCA1 complex dependent DNA damage response
- (2017) Yunhui Li et al. Nature Communications
- Let-7e sensitizes epithelial ovarian cancer to cisplatin through repressing DNA double strand break repair
- (2017) Man Xiao et al. Journal of Ovarian Research
- LncRNA UCA1 promotes proliferation and cisplatin resistance of oral squamous cell carcinoma by sunppressing miR-184 expression
- (2017) Zheng Fang et al. Cancer Medicine
- ZBTB7A Enhances Osteosarcoma Chemoresistance by Transcriptionally Repressing lncRNALINC00473-IL24 Activity
- (2017) Lu Zhang et al. NEOPLASIA
- MiR-200c regulates tumor growth and chemosensitivity to cisplatin in osteosarcoma by targeting AKT2
- (2017) Yang Liu et al. Scientific Reports
- MRP4/ABCC4 As a New Therapeutic Target: Meta-Analysis to Determine cAMP Binding Sites as a Tool for Drug Design
- (2017) Agustín Yaneff et al. CURRENT MEDICINAL CHEMISTRY
- Hypoxia-inducible factor 3 biology: complexities and emerging themes
- (2016) Cunming Duan AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY
- KLF5 mediates vascular remodeling via HIF-1α in hypoxic pulmonary hypertension
- (2016) Xiaochen Li et al. AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY
- Role for DUSP1 (dual-specificity protein phosphatase 1) in the regulation of autophagy
- (2016) Juan Wang et al. Autophagy
- GFRA1 promotes cisplatin-induced chemoresistance in osteosarcoma by inducing autophagy
- (2016) Mihwa Kim et al. Autophagy
- Lobaplatin induces BGC-823 human gastric carcinoma cell apoptosis via ROS- mitochondrial apoptotic pathway and impairs cell migration and invasion
- (2016) Yali Li et al. BIOMEDICINE & PHARMACOTHERAPY
- A phase 2 study of nanoparticle albumin-bound paclitaxel plus nedaplatin for patients with advanced, recurrent, or metastatic cervical carcinoma
- (2016) Yifan Li et al. CANCER
- Long non-coding RNA UCA1 promotes cisplatin/gemcitabine resistance through CREB modulating miR-196a-5p in bladder cancer cells
- (2016) Jingjing Pan et al. CANCER LETTERS
- Overcoming cisplatin resistance of ovarian cancer cells by targeting HIF-1-regulated cancer metabolism
- (2016) Zhihong Ai et al. CANCER LETTERS
- Lung cancer stem cells: The root of resistance
- (2016) Lauren MacDonagh et al. CANCER LETTERS
- Effector T Cells Abrogate Stroma-Mediated Chemoresistance in Ovarian Cancer
- (2016) Weimin Wang et al. CELL
- The African-specific S47 polymorphism of p53 alters chemosensitivity
- (2016) Subhasree Basu et al. CELL CYCLE
- Microenvironmental InterFereNce of metabolism regulates chemosensitivity
- (2016) Leila Akkari et al. CELL RESEARCH
- An African-specific polymorphism in theTP53gene impairs p53 tumor suppressor function in a mouse model
- (2016) Matthew Jennis et al. GENES & DEVELOPMENT
- MiR-99a and MiR-491 Regulate Cisplatin Resistance in Human Gastric Cancer Cells by Targeting CAPNS1
- (2016) Yajie Zhang et al. International Journal of Biological Sciences
- Higher expression of XPF is a critical factor in intrinsic chemotherapy resistance of human renal cell carcinoma
- (2016) Qiao Zhang et al. INTERNATIONAL JOURNAL OF CANCER
- RmiR-133a enhances the sensitivity of Hep-2 cells and vincristine-resistant Hep-2v cells to cisplatin by downregulating ATP7B expression
- (2016) XURUI WANG et al. INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
- miR-409-3p sensitizes colon cancer cells to oxaliplatin by inhibiting Beclin-1-mediated autophagy
- (2016) SHIFAN TAN et al. INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
- miR-17-92 plays an oncogenic role and conveys chemo-resistance to cisplatin in human prostate cancer cells
- (2016) PENG ZHOU et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Cisplatin-induced CCL5 secretion from CAFs promotes cisplatin-resistance in ovarian cancer via regulation of the STAT3 and PI3K/Akt signaling pathways
- (2016) BO ZHOU et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Cathepsin Protease Controls Copper and Cisplatin Accumulation via Cleavage of the Ctr1 Metal-binding Ectodomain
- (2016) Helena Öhrvik et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Copper transporters and chaperones CTR1, CTR2, ATOX1, and CCS as determinants of cisplatin sensitivity
- (2016) Kristin M. Bompiani et al. Metallomics
- Functional Activation of Mutant p53 by Platinum Analogues in Cisplatin-Resistant Cells Is Dependent on Phosphorylation
- (2016) Xiaolei Xie et al. MOLECULAR CANCER RESEARCH
- The FA/BRCA Pathway Identified as the Major Predictor of Cisplatin Response in Head and Neck Cancer by Functional Genomics
- (2016) Sanne R. Martens-de Kemp et al. MOLECULAR CANCER THERAPEUTICS
- OCT2 demethylation cracks open oxaliplatin resistance
- (2016) Andrea Aguilar Nature Reviews Nephrology
- Oxaliplatin-Based Chemotherapy in Advanced Neuroendocrine Tumors: Clinical Outcomes and Preliminary Correlation with Biological Factors
- (2016) Francesca Spada et al. NEUROENDOCRINOLOGY
- Wwox–Brca1 interaction: role in DNA repair pathway choice
- (2016) M S Schrock et al. ONCOGENE
- miR-374a-CCND1-pPI3K/AKT-c-JUN feedback loop modulated by PDCD4 suppresses cell growth, metastasis and sensitizes nasopharyngeal carcinoma to cisplatin
- (2016) Y Zhen et al. ONCOGENE
- Downregulation of YEATS4 by miR-218 sensitizes colorectal cancer cells to L-OHP-induced cell apoptosis by inhibiting cytoprotective autophagy
- (2016) Qiang Fu et al. ONCOLOGY REPORTS
- Enhancement of Drug Sensitivity by Knockdown of HIF-1α in Gastric Carcinoma Cells
- (2016) Qun Zhao et al. ONCOLOGY RESEARCH
- Therapeutic targeting of hypoxia and hypoxia-inducible factors in cancer
- (2016) Caroline Wigerup et al. PHARMACOLOGY & THERAPEUTICS
- Epigenetic activation of the drug transporter OCT2 sensitizes renal cell carcinoma to oxaliplatin
- (2016) Yanqing Liu et al. Science Translational Medicine
- A phosphotyrosine switch regulates organic cation transporters
- (2016) Jason A. Sprowl et al. Nature Communications
- Ammonium tetrathiomolybdate treatment targets the copper transporter ATP7A and enhances sensitivity of breast cancer to cisplatin
- (2016) Cristine L. Chisholm et al. Oncotarget
- Cancer-associated fibroblasts treated with cisplatin facilitates chemoresistance of lung adenocarcinoma through IL-11/IL-11R/STAT3 signaling pathway
- (2016) Leilei Tao et al. Scientific Reports
- The Essential Role of H19 Contributing to Cisplatin Resistance by Regulating Glutathione Metabolism in High-Grade Serous Ovarian Cancer
- (2016) Zhi-Guo Zheng et al. Scientific Reports
- Multi-institutional prospective study of nedaplatin plus S-1 chemotherapy in recurrent and metastatic nasopharyngeal carcinoma patients after failure of platinum-containing regimens
- (2016) Pei-Jian Peng et al. Therapeutic Advances in Medical Oncology
- β-elemene sensitizes hepatocellular carcinoma cells to oxaliplatin by preventing oxaliplatin-induced degradation of copper transporter 1
- (2016) Xiaoqiang Li et al. Scientific Reports
- miRNA-378 reverses chemoresistance to cisplatin in lung adenocarcinoma cells by targeting secreted clusterin
- (2016) Xuesong Chen et al. Scientific Reports
- Overexpression of long non-coding RNA PVT1 in gastric cancer cells promotes the development of multidrug resistance
- (2015) Xian-wen Zhang et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Catechols and 3-hydroxypyridones as inhibitors of the DNA repair complex ERCC1-XPF
- (2015) Timothy M. Chapman et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- HMGB1-mediated autophagy modulates sensitivity of colorectal cancer cells to oxaliplatin via MEK/ERK signaling pathway
- (2015) Weijun Liu et al. CANCER BIOLOGY & THERAPY
- Serum metallothionein in patients with testicular cancer
- (2015) Blanka Tariba et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Autophagy contributes to the enrichment and survival of colorectal cancer stem cells under oxaliplatin treatment
- (2015) Hao-Zheng Yang et al. CANCER LETTERS
- Xc− inhibitor sulfasalazine sensitizes colorectal cancer to cisplatin by a GSH-dependent mechanism
- (2015) Ming-zhe Ma et al. CANCER LETTERS
- miR-634 Activates the Mitochondrial Apoptosis Pathway and Enhances Chemotherapy-Induced Cytotoxicity
- (2015) Naoto Fujiwara et al. CANCER RESEARCH
- Heparanase Enhances Tumor Growth and Chemoresistance by Promoting Autophagy
- (2015) Anna Shteingauz et al. CANCER RESEARCH
- MiR-205 and miR-218 expression is associated with carboplatin chemoresistance and regulation of apoptosis via Mcl-1 and Survivin in lung cancer cells
- (2015) Paul Zarogoulidis et al. CELLULAR SIGNALLING
- Role of mismatch repair proteins in the processing of cisplatin interstrand cross-links
- (2015) Akshada Sawant et al. DNA REPAIR
- The overexpression and nuclear translocation of Trx-1 during hypoxia confers on HepG2 cells resistance to DDP, and GL-V9 reverses the resistance by suppressing the Trx-1/Ref-1 axis
- (2015) Li Zhao et al. FREE RADICAL BIOLOGY AND MEDICINE
- Targeting autophagy to overcome drug resistance in cancer therapy
- (2015) Ankit Kumar et al. Future Medicinal Chemistry
- A common polymorphism in the 5′ UTR of ERCC5 creates an upstream ORF that confers resistance to platinum-based chemotherapy
- (2015) Joanna Somers et al. GENES & DEVELOPMENT
- Resistance to therapy inBRCA2mutant cells due to loss of the nucleosome remodeling factor CHD4
- (2015) Shawna Guillemette et al. GENES & DEVELOPMENT
- The anti-malarial chloroquine suppresses proliferation and overcomes cisplatin resistance of endometrial cancer cells via autophagy inhibition
- (2015) Tomohiko Fukuda et al. GYNECOLOGIC ONCOLOGY
- Autophagic flux promotes cisplatin resistance in human ovarian carcinoma cells through ATP-mediated lysosomal function
- (2015) LIWEI MA et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- NF-κB signaling plays irreplaceable roles in cisplatin-induced bladder cancer chemoresistance and tumor progression
- (2015) YI SUN et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- miR-873 acts as a novel sensitizer of glioma cells to cisplatin by targeting Bcl-2
- (2015) XIONG CHEN et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Inhibition of cisplatin-resistance by RNA interference targeting metallothionein using reducible oligo-peptoplex
- (2015) Jong-Hwan Lee et al. JOURNAL OF CONTROLLED RELEASE
- miR-148b reverses cisplatin-resistance in non-small cell cancer cells via negatively regulating DNA (cytosine-5)-methyltransferase 1(DNMT1) expression
- (2015) Chengguang Sui et al. Journal of Translational Medicine
- miR-634 restores drug sensitivity in resistant ovarian cancer cells by targeting the Ras-MAPK pathway
- (2015) Marijn T. M. van Jaarsveld et al. Molecular Cancer
- MEK Inhibition Overcomes Cisplatin Resistance Conferred by SOS/MAPK Pathway Activation in Squamous Cell Carcinoma
- (2015) L. R. Kong et al. MOLECULAR CANCER THERAPEUTICS
- CRISPR-Cas9–based target validation for p53-reactivating model compounds
- (2015) Michael Wanzel et al. Nature Chemical Biology
- CITED2 silencing sensitizes cancer cells to cisplatin by inhibiting p53 trans-activation and chromatin relaxation on the ERCC1 DNA repair gene
- (2015) Yu-Chin Liu et al. NUCLEIC ACIDS RESEARCH
- Dihydromyricetin Enhances the Chemo-Sensitivity of Nedaplatin via Regulation of the p53/Bcl-2 Pathway in Hepatocellular Carcinoma Cells
- (2015) Lianggui Jiang et al. PLoS One
- Erratum: Glutathione depletion sensitizes cisplatin- and temozolomide-resistant glioma cells in vitro and in vivo
- (2015) C R R Rocha et al. Cell Death & Disease
- EGCG Enhances Cisplatin Sensitivity by Regulating Expression of the Copper and Cisplatin Influx Transporter CTR1 in Ovary Cancer
- (2015) Xuemin Wang et al. PLoS One
- Multidrug Resistance-Associated Protein 2 (MRP2) Mediated Transport of Oxaliplatin-Derived Platinum in Membrane Vesicles
- (2015) Khine Myint et al. PLoS One
- Mechanism of Cisplatin-Induced Cytotoxicity Is Correlated to Impaired Metabolism Due to Mitochondrial ROS Generation
- (2015) Yong-Min Choi et al. PLoS One
- Chromatin status of apoptosis genes correlates with sensitivity to chemo-, immune- and radiation therapy in colorectal cancer cell lines
- (2014) Anne Benard et al. APOPTOSIS
- Overall survival and clinical characteristics of pancreatic cancer in BRCA mutation carriers
- (2014) T Golan et al. BRITISH JOURNAL OF CANCER
- Induction of autophagy counteracts the anticancer effect of cisplatin in human esophageal cancer cells with acquired drug resistance
- (2014) Le Yu et al. CANCER LETTERS
- Pharmacogenetics of the DNA repair pathways in advanced non-small cell lung cancer patients treated with platinum-based chemotherapy
- (2014) Ivana Sullivan et al. CANCER LETTERS
- miR-let-7f-1 regulates SPARC mediated cisplatin resistance in medulloblastoma cells
- (2014) Padmavathi Pannuru et al. CELLULAR SIGNALLING
- Reduced Expression of miRNA-27a Modulates Cisplatin Resistance in Bladder Cancer by Targeting the Cystine/Glutamate Exchanger SLC7A11
- (2014) R. M. Drayton et al. CLINICAL CANCER RESEARCH
- Copper transporter CTR1 expression and tissue platinum concentration in non-small cell lung cancer
- (2014) Eric S. Kim et al. LUNG CANCER
- Copper transporter 2 regulates intracellular copper and sensitivity to cisplatin
- (2014) Carlos P. Huang et al. Metallomics
- Epithelial–mesenchymal status renders differential responses to cisplatin in ovarian cancer
- (2014) Q H Miow et al. ONCOGENE
- JWA reverses cisplatin resistance via the CK2—XRCC1 pathway in human gastric cancer cells
- (2014) W Xu et al. Cell Death & Disease
- Targeting Apoptosis Pathways for New Cancer Therapeutics
- (2013) Longchuan Bai et al. Annual Review of Medicine
- Enhanceosomes as integrators of hypoxia inducible factor (HIF) and other transcription factors in the hypoxic transcriptional response
- (2013) Matthew R. Pawlus et al. CELLULAR SIGNALLING
- Prostate Cancer, miRNAs, Metallothioneins and Resistance to Cytostatic Drugs
- (2013) V. Pekarik et al. CURRENT MEDICINAL CHEMISTRY
- Autophagic control of cell ‘stemness’
- (2013) Huize Pan et al. EMBO Molecular Medicine
- Impaired Glutathione Synthesis in Neurodegeneration
- (2013) Koji Aoyama et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- miR-495 Enhances the Sensitivity of Non-Small Cell Lung Cancer Cells to Platinum by Modulation of Copper-Transporting P-type Adenosine Triphosphatase A (ATP7A)
- (2013) Liqiang Song et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- In Brief:BRCA1andBRCA2
- (2013) William D Foulkes et al. JOURNAL OF PATHOLOGY
- Chk1/2 Inhibition Overcomes the Cisplatin Resistance of Head and Neck Cancer Cells Secondary to the Loss of Functional p53
- (2013) M. A. Gadhikar et al. MOLECULAR CANCER THERAPEUTICS
- Endoplasmic Reticulum Stress Is Involved in the Response of Human Laryngeal Carcinoma Cells to Carboplatin but Is Absent in Carboplatin-Resistant Cells
- (2013) Anamaria Brozovic et al. PLoS One
- Zinc chelation: a metallothionein 2A’s mechanism of action involved in osteosarcoma cell death and chemotherapy resistance
- (2013) N Habel et al. Cell Death & Disease
- Carboplatin and oxaliplatin in sequenced combination with bortezomib in ovarian tumour models
- (2013) Zaynab Al-Eisawi et al. Journal of Ovarian Research
- DNA damage-induced cell death: From specific DNA lesions to the DNA damage response and apoptosis
- (2012) Wynand P. Roos et al. CANCER LETTERS
- BRCA1/2 mutations and expression: Response to platinum chemotherapy in patients with advanced stage epithelial ovarian cancer
- (2012) Rebecca Byler Dann et al. GYNECOLOGIC ONCOLOGY
- Replacement of cisplatin with nedaplatin in a definitive 5-fluorouracil/cisplatin-based chemoradiotherapy in Japanese patients with esophageal squamous cell carcinoma
- (2012) Akiko Kuwahara et al. International Journal of Medical Sciences
- The CXXC motifs in the metal binding domains are required for ATP7B to mediate resistance to cisplatin
- (2012) Roohangiz Safaei et al. JOURNAL OF INORGANIC BIOCHEMISTRY
- Hypoxia inducible factor-1α induces chemoresistance phenotype in non-Hodgkin lymphoma cell line via up-regulation of Bcl-xL
- (2012) Marco A. Hernandez-Luna et al. LEUKEMIA & LYMPHOMA
- Overcoming Platinum Resistance through the Use of a Copper-Lowering Agent
- (2012) Siqing Fu et al. MOLECULAR CANCER THERAPEUTICS
- Suppression of Jab1/CSN5 induces radio- and chemo-sensitivity in nasopharyngeal carcinoma through changes to the DNA damage and repair pathways
- (2012) Y Pan et al. ONCOGENE
- Low ERCC1 expression is associated with prolonged survival in patients with bladder cancer receiving platinum-based neoadjuvant chemotherapy
- (2012) Muhammet Fuat Ozcan et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- Resistance and gain-of-resistance phenotypes in cancers harboring wild-type p53
- (2011) Michelle Martinez-Rivera et al. BIOCHEMICAL PHARMACOLOGY
- Role of multidrug resistance protein 2 (MRP2) in chemoresistance and clinical outcome in oesophageal squamous cell carcinoma
- (2011) M Yamasaki et al. BRITISH JOURNAL OF CANCER
- Role of Endonucleases XPF and XPG in Nucleotide Excision Repair of Platinated DNA and Cisplatin/Oxaliplatin Cytotoxicity
- (2011) Nora Graf et al. CHEMBIOCHEM
- Secondary Somatic Mutations Restoring BRCA1/2 Predict Chemotherapy Resistance in Hereditary Ovarian Carcinomas
- (2011) Barbara Norquist et al. JOURNAL OF CLINICAL ONCOLOGY
- The Mutational Landscape of Head and Neck Squamous Cell Carcinoma
- (2011) N. Stransky et al. SCIENCE
- Targeting the pro-death and pro-survival functions of autophagy as novel therapeutic strategies in cancer
- (2010) Kevin Dalby et al. Autophagy
- Differential transport of platinum compounds by the human organic cation transporter hOCT2 (hSLC22A2)
- (2010) H Burger et al. BRITISH JOURNAL OF PHARMACOLOGY
- Enhancing Tumor-Specific Uptake of the Anticancer Drug Cisplatin with a Copper Chelator
- (2010) Seiko Ishida et al. CANCER CELL
- The relationship between cisplatin-induced reactive oxygen species, glutathione, and BCL-2 and resistance to cisplatin
- (2010) Anamaria Brozovic et al. CRITICAL REVIEWS IN TOXICOLOGY
- The status of platinum anticancer drugs in the clinic and in clinical trials
- (2010) Nial J. Wheate et al. DALTON TRANSACTIONS
- Downregulation of XPF–ERCC1 enhances cisplatin efficacy in cancer cells☆
- (2010) Sanjeevani Arora et al. DNA REPAIR
- An Adsorptive Transfer Technique Coupled with Brdicka Reaction to Reveal the Importance of Metallothionein in Chemotherapy with Platinum Based Cytostatics
- (2010) Sona Krizkova et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Driver mutations in TP53 are ubiquitous in high grade serous carcinoma of the ovary
- (2010) Ahmed Ashour Ahmed et al. JOURNAL OF PATHOLOGY
- Copper Transporter 2 Regulates Endocytosis and Controls Tumor Growth and Sensitivity to Cisplatin In Vivo
- (2010) B. G. Blair et al. MOLECULAR PHARMACOLOGY
- Copper Transporters and the Cellular Pharmacology of the Platinum-Containing Cancer Drugs
- (2010) S. B. Howell et al. MOLECULAR PHARMACOLOGY
- Hypoxia-Inducible Factor 1α Determines Gastric Cancer Chemosensitivity via Modulation of p53 and NF-κB
- (2010) Nadine Rohwer et al. PLoS One
- Cisplatin interaction with amino acids cysteine and methionine from gas phase to solutions with constant pH
- (2010) Tomáš Zimmermann et al. Interdisciplinary Sciences-Computational Life Sciences
- Increased levels and defective glycosylation of MRPs in ovarian carcinoma cells resistant to oxaliplatin
- (2009) Giovanni Luca Beretta et al. BIOCHEMICAL PHARMACOLOGY
- Hypoxia-inducible factor-1 alpha, in association with inflammation, angiogenesis and MYC, is a critical prognostic factor in patients with HCC after surgery
- (2009) Chen-Xin Dai et al. BMC CANCER
- Silencing MRP4 by small interfering RNA reverses acquired DDP resistance of gastric cancer cell
- (2009) Yan-Hong Zhang et al. CANCER LETTERS
- Modes of p53 Regulation
- (2009) Jan-Philipp Kruse et al. CELL
- Copper Transporter 2 Regulates the Cellular Accumulation and Cytotoxicity of Cisplatin and Carboplatin
- (2009) B. G. Blair et al. CLINICAL CANCER RESEARCH
- Human copper transporters: mechanism, role in human diseases and therapeutic potential
- (2009) Arnab Gupta et al. Future Medicinal Chemistry
- Increased levels of copper efflux transporter ATP7B are associated with poor outcome in colorectal cancer patients receiving oxaliplatin-based chemotherapy
- (2009) Eva Martinez-Balibrea et al. INTERNATIONAL JOURNAL OF CANCER
- Crystal Structures of Cisplatin Bound to a Human Copper Chaperone
- (2009) Amie K. Boal et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- The ERCC1/XPF endonuclease is required for completion of homologous recombination at DNA replication forks stalled by inter-strand cross-links
- (2009) A. Z. Al-Minawi et al. NUCLEIC ACIDS RESEARCH
- Prognostic significance of hypoxia-inducible factor-1 , TWIST1 and Snail expression in resectable non-small cell lung cancer
- (2009) J-J Hung et al. THORAX
- Altered localisation of the copper efflux transporters ATP7A and ATP7B associated with cisplatin resistance in human ovarian carcinoma cells
- (2008) Ganna V Kalayda et al. BMC CANCER
- Oxidative Stress Is Inherent in Prostate Cancer Cells and Is Required for Aggressive Phenotype
- (2008) B. Kumar et al. CANCER RESEARCH
- Transcriptional control of human p53-regulated genes
- (2008) Todd Riley et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- The Role of Cellular Accumulation in Determining Sensitivity to Platinum-Based Chemotherapy
- (2007) Matthew D. Hall et al. Annual Review of Pharmacology and Toxicology
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now